by microbiome | Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work
Association between the gut-brain-beta cell glucagon-like peptide-1(GLP-1)-dependent axis, the gut microbiota and the insulin sensitivity Grasset et al. explored the association between the gut-brain-beta cell glucagon-like peptide-1 (GLP-1)-dependent axis, the gut...
by microbiome | Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work
Liraglutide targets the gut microbiota and the glucolipid metabolism to regulate insulin secretion Charpentier and colleagues showed that Liraglutide targets the gut microbiota and the glucolipid metabolism to regulate insulin secretion: → T2D is characterized...
by microbiome | Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work
The tight crosstalk between the intestinal immune system and the microbiota in glucose intolerance In this article, Pomié et al. study the importance of the tight crosstalk between the intestinal immune system and the microbiota in metabolic disorders: → The...
by microbiome | Mar 22, 2023 | Highlights, Microbiomes & Metabolism, Vaiomer original work
Identification of tissue-specific variations of the microbiome resulting from endurance training Villarroel and colleagues (2022) explored the contribution of tissue microbiome on muscle function in Endurance Training: → The authors explored blood and skeletal muscle...
by microbiome | Dec 6, 2022 | Highlights, News
Vaiomer is happy to announce that we will be attending the 2022 edition of « Journées Polepharma De Microbiomique »on December 14th & 15th Rouen, FRANCE. Vaiomer’s representatives, Benjamin LELOUVIER (CSO) and Anne DEFLISQUE (Sales & Marketing Director) will...
